Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(1.91)
# 3,092
Out of 4,944 analysts
792
Total ratings
33.46%
Success rate
-8.98%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNSE Sensei Biotherapeutics | Maintains: Buy | $5 → $30 | $7.56 | +296.95% | 1 | Aug 5, 2025 | |
| NVCT Nuvectis Pharma | Maintains: Buy | $15 → $10 | $6.62 | +51.17% | 10 | Aug 4, 2025 | |
| VYNE VYNE Therapeutics | Downgrades: Neutral | n/a | $0.35 | - | 23 | Jul 30, 2025 | |
| KRYS Krystal Biotech | Reiterates: Buy | $240 | $143.62 | +67.11% | 32 | Jul 25, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $77 → $24 | $8.04 | +198.51% | 24 | Jul 11, 2025 | |
| TVTX Travere Therapeutics | Assumes: Buy | $30 | $17.41 | +72.31% | 1 | Jul 1, 2025 | |
| PDSB PDS Biotechnology | Reiterates: Buy | $13 | $1.23 | +956.91% | 32 | Jul 1, 2025 | |
| EWTX Edgewise Therapeutics | Initiates: Buy | $42 | $13.39 | +213.67% | 1 | Jun 30, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $102 | $39.86 | +155.90% | 33 | Jun 25, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $14 | $2.14 | +554.21% | 2 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $53 | $62.00 | -14.52% | 2 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.06 | +277.36% | 22 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.51 | +164.90% | 31 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.01 | +791.09% | 12 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.66 | +504.14% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.79 | +793.85% | 29 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $3.77 | +59.15% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $3.75 | +593.33% | 14 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $23.80 | +110.08% | 35 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $6.65 | +140.60% | 20 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.27 | +690.51% | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $5.23 | +569.22% | 9 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.55 | - | 4 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $104 | $28.18 | +269.06% | 24 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $2.46 | +265.85% | 15 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $1.65 | +930.30% | 1 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $10.91 | +193.31% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $15 | $0.56 | +2,569.04% | 15 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.48 | +545.16% | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $250 | $9.25 | +2,602.70% | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $20 | $2.23 | +796.86% | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $0.77 | +1,064.29% | 1 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $18 | $1.65 | +990.91% | 30 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $6.20 | +545.16% | 26 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.76 | +560.50% | 16 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $3.17 | +657.10% | 18 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $34.31 | +249.75% | 48 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 | $8.81 | +81.61% | 19 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.75 | - | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $3.70 | +737.84% | 31 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.12 | +971.43% | 1 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.76 | - | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $11.20 | +230.36% | 17 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.96 | +461.22% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $34.52 | +65.12% | 26 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $21 | $7.36 | +185.34% | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.70 | +1,076.47% | 14 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.74 | +1,336.78% | 16 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.62 | +472.52% | 16 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $26 | $2.01 | +1,193.53% | 3 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $3.29 | +659.88% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.70 | +5,782.35% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.01 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $32 | $1.92 | +1,571.02% | 4 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $30 | $1.81 | +1,557.46% | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.56 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $27.12 | +21.68% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $8.21 | +850.06% | 1 | Mar 24, 2017 |
Sensei Biotherapeutics
Aug 5, 2025
Maintains: Buy
Price Target: $5 → $30
Current: $7.56
Upside: +296.95%
Nuvectis Pharma
Aug 4, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $6.62
Upside: +51.17%
VYNE Therapeutics
Jul 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.35
Upside: -
Krystal Biotech
Jul 25, 2025
Reiterates: Buy
Price Target: $240
Current: $143.62
Upside: +67.11%
Capricor Therapeutics
Jul 11, 2025
Maintains: Buy
Price Target: $77 → $24
Current: $8.04
Upside: +198.51%
Travere Therapeutics
Jul 1, 2025
Assumes: Buy
Price Target: $30
Current: $17.41
Upside: +72.31%
PDS Biotechnology
Jul 1, 2025
Reiterates: Buy
Price Target: $13
Current: $1.23
Upside: +956.91%
Edgewise Therapeutics
Jun 30, 2025
Initiates: Buy
Price Target: $42
Current: $13.39
Upside: +213.67%
Viking Therapeutics
Jun 25, 2025
Reiterates: Buy
Price Target: $102
Current: $39.86
Upside: +155.90%
Phio Pharmaceuticals
Jun 25, 2025
Reiterates: Buy
Price Target: $14
Current: $2.14
Upside: +554.21%
Jun 24, 2025
Maintains: Buy
Price Target: $41 → $53
Current: $62.00
Upside: -14.52%
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.06
Upside: +277.36%
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.51
Upside: +164.90%
Jun 23, 2025
Reiterates: Buy
Price Target: $9
Current: $1.01
Upside: +791.09%
Jun 18, 2025
Reiterates: Buy
Price Target: $4
Current: $0.66
Upside: +504.14%
Jun 17, 2025
Reiterates: Buy
Price Target: $16
Current: $1.79
Upside: +793.85%
Jun 17, 2025
Assumes: Buy
Price Target: $6
Current: $3.77
Upside: +59.15%
Jun 17, 2025
Reiterates: Buy
Price Target: $26
Current: $3.75
Upside: +593.33%
Jun 16, 2025
Reiterates: Buy
Price Target: $50
Current: $23.80
Upside: +110.08%
Jun 13, 2025
Reiterates: Buy
Price Target: $16
Current: $6.65
Upside: +140.60%
Jun 11, 2025
Reiterates: Buy
Price Target: $10
Current: $1.27
Upside: +690.51%
Jun 4, 2025
Reiterates: Buy
Price Target: $35
Current: $5.23
Upside: +569.22%
Jun 2, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.55
Upside: -
May 28, 2025
Reiterates: Buy
Price Target: $104
Current: $28.18
Upside: +269.06%
May 19, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $2.46
Upside: +265.85%
May 19, 2025
Assumes: Buy
Price Target: $17
Current: $1.65
Upside: +930.30%
May 16, 2025
Reiterates: Buy
Price Target: $32
Current: $10.91
Upside: +193.31%
May 16, 2025
Maintains: Buy
Price Target: $21 → $15
Current: $0.56
Upside: +2,569.04%
May 15, 2025
Reiterates: Buy
Price Target: $16
Current: $2.48
Upside: +545.16%
May 13, 2025
Reiterates: Buy
Price Target: $250
Current: $9.25
Upside: +2,602.70%
May 9, 2025
Maintains: Buy
Price Target: $32 → $20
Current: $2.23
Upside: +796.86%
May 8, 2025
Assumes: Buy
Price Target: $9
Current: $0.77
Upside: +1,064.29%
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $1.65
Upside: +990.91%
Apr 28, 2025
Reiterates: Buy
Price Target: $40
Current: $6.20
Upside: +545.16%
Apr 25, 2025
Reiterates: Buy
Price Target: $5
Current: $0.76
Upside: +560.50%
Apr 21, 2025
Reiterates: Buy
Price Target: $24
Current: $3.17
Upside: +657.10%
Apr 21, 2025
Reiterates: Buy
Price Target: $120
Current: $34.31
Upside: +249.75%
Apr 10, 2025
Downgrades: Neutral
Price Target: $16
Current: $8.81
Upside: +81.61%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.75
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $3.70
Upside: +737.84%
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $1.12
Upside: +971.43%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.76
Upside: -
Mar 21, 2025
Reiterates: Buy
Price Target: $37
Current: $11.20
Upside: +230.36%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.96
Upside: +461.22%
Mar 5, 2025
Reiterates: Buy
Price Target: $57
Current: $34.52
Upside: +65.12%
Feb 4, 2025
Maintains: Buy
Price Target: $8 → $21
Current: $7.36
Upside: +185.34%
Jan 15, 2025
Reiterates: Buy
Price Target: $20
Current: $1.70
Upside: +1,076.47%
Dec 18, 2024
Reiterates: Buy
Price Target: $25
Current: $1.74
Upside: +1,336.78%
Dec 11, 2024
Reiterates: Buy
Price Target: $15
Current: $2.62
Upside: +472.52%
Nov 18, 2024
Maintains: Buy
Price Target: $24 → $26
Current: $2.01
Upside: +1,193.53%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $3.29
Upside: +659.88%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $1.70
Upside: +5,782.35%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $2.01
Upside: -
Feb 25, 2021
Maintains: Buy
Price Target: $36 → $32
Current: $1.92
Upside: +1,571.02%
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $1.81
Upside: +1,557.46%
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $2.56
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $27.12
Upside: +21.68%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $8.21
Upside: +850.06%